by John Conrad | Jan 5, 2024 | iBIO in the News
On January 3rd iBIO president & CEO, John Conrad, joined his biosciences colleagues from across the country to ring the closing bell at the New York Stock Exchange (NYSE). And to talk about the industry in 2024 and the amazing growth of our life sciences industry...
by John Conrad | Jun 6, 2023 | iBIO in the News
Today, the Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on the best practices in state bioscience economic development measures, “The U.S. Biosciences Industry in the...
by John Conrad | Mar 16, 2023 | iBIO in the News
PCI Pharma Services, a Philadelphia contract drug manufacturer, is investing $50 million into a new manufacturing facility in Rockford that’s expected to create about 250 jobs. The 200,000-square-foot site will enhance the company’s ability to create a...
by John Conrad | Feb 16, 2023 | iBIO in the News
Another biotech startup announced plans to move into downtown Chicago this week in just the latest addition to the city’s burgeoning life-sciences sector — an industry that may help reshape Chicago’s real estate coming out of Covid. Arriving in the Windy...
by John Conrad | Dec 2, 2022 | iBIO in the News, iBIO News
Falling behind in education jeopardizes the future competitiveness of the region and country, especially in STEM fields where the U.S. already lags some other nations. In Illinois, only 25.8% of students in grades 3-8 met or exceeded state standards in math, down 6.2%...
by John Conrad | Oct 31, 2022 | iBIO in the News
Illinois’ bioscience industry has seen major growth in recent years as government grants and private investors have pumped money into the sector, according to a new report. But a shaky economy and venture-capital slowdown this year will likely hamstring...